Loktionov Alexey Valerevich, Kobzeva Ksenia Andreevna, Karpenko Andrey Romanovich, Sergeeva Vera Alexeevna, Orlov Yuriy Lvovich, Bushueva Olga Yurievna
Department of Anesthesia and Critical Care, Institute of Continuing Education, Kursk State Medical University, Kursk, Russia.
Laboratory of Genomic Research, Research Institute for Genetic and Molecular Epidemiology, Kursk State Medical University, Kursk, Russia.
Front Genet. 2024 Aug 8;15:1434681. doi: 10.3389/fgene.2024.1434681. eCollection 2024.
The aim of this study was to replicate associations of GWAS-significant loci with severe COVID-19 in the population of Central Russia, to investigate associations of the SNPs with thromboinflammation parameters, to analyze gene-gene and gene-environmental interactions.
DNA samples from 798 unrelated Caucasian subjects from Central Russia (199 hospitalized COVID-19 patients and 599 controls with a mild or asymptomatic course of COVID-19) were genotyped using probe-based polymerase chain reaction for 10 GWAS-significant SNPs: rs143334143 , rs111837807 , rs17078346 , rs17713054 , rs7949972 , rs61882275 , rs12585036 , rs67579710 , rs12610495 , rs9636867 .
SNP rs17713054 was associated with increased risk of severe COVID-19 in the entire group (risk allele A, OR = 1.78, 95% CI = 1.22-2.6, = 0.003), obese individuals (OR = 2.31, 95% CI = 1.52-3.5, = 0.0002, ( = 0.0004)), patients with low fruit and vegetable intake (OR = 1.72, 95% CI = 1.15-2.58, = 0.01, ( = 0.02)), low physical activity (OR = 1.93, 95% CI = 1.26-2.94, = 0.0035, ( = 0.007)), and nonsmokers (OR = 1.65, 95% CI = 1.11-2.46, = 0.02). This SNP correlated with increased BMI ( = 0.006) and worsened thrombodynamic parameters (maximum optical density of the formed clot, D ( = 0.02), delayed appearance of spontaneous clots, Tsp ( = 0.02), clot size 30 min after coagulation activation, CS ( = 0.036)). SNP rs17078346 was linked with increased BMI ( = 0.01) and severe COVID-19 in obese individuals (risk allele C, OR = 1.72, 95% CI = 1.15-2.58, = 0.01, ( = 0.02)). SNP rs12610495 was associated with increased BMI ( = 0.01), severe COVID-19 in obese patients (risk allele G, OR = 1.48, 95% CI = 1.09-2.01, = 0.01, ( = 0.02)), and worsened thrombodynamic parameters (time to the start of clot growth, Tlag ( = 0.01)). For rs7949972 , a protective effect against severe COVID-19 was observed in non-obese patients (effect allele T, OR = 0.67, 95% CI = 0.47-0.95, = 0.02, ( = 0.04)), improving thrombodynamic parameters (CS ( = 0.02), stationary spatial clot growth rates, Vst ( = 0.02)). Finally, rs12585036 exhibited a protective effect against severe COVID-19 in males (protective allele A, OR = 0.51, 95% CI = 0.32-0.83, = 0.004). SNPs rs67579710 , -, rs17713054 , rs7949972 rs9636867 -were involved in two or more of the most significant G×G interactions ( ≤ 0.01). The pairwise combination rs67579710 , - × rs17713054 was a priority in determining susceptibility to severe COVID-19 (it was included in four of the top five most significant SNP-SNP interaction models).
Overall, this study represents a comprehensive molecular-genetic and bioinformatics analysis of the involvement of GWAS-significant loci in the molecular mechanisms of severe COVID-19, gene-gene and gene-environmental interactions, and provides evidence of their relationship with thromboinflammation parameters in patients hospitalized in intensive care units.
本研究旨在在俄罗斯中部人群中重复全基因组关联研究(GWAS)显著位点与重症 COVID-19 的关联,研究单核苷酸多态性(SNP)与血栓炎症参数的关联,分析基因-基因和基因-环境相互作用。
使用基于探针的聚合酶链反应对来自俄罗斯中部的 798 名无亲缘关系的白种人(199 例住院 COVID-19 患者和 599 例 COVID-19 症状轻微或无症状的对照)的 DNA 样本进行 10 个 GWAS 显著 SNP 的基因分型:rs143334143、rs111837807、rs17078346、rs17713054、rs7949972、rs61882275、rs12585036、rs67579710、rs12610495、rs9636867。
SNP rs17713054 与整个组中重症 COVID-19 风险增加相关(风险等位基因 A,比值比(OR)=1.78,95%置信区间(CI)=1.22-2.6,P = 0.003),在肥胖个体中(OR = 2.31,95%CI = 1.52-3.5,P = 0.0002,(校正 P = 0.0004)),水果和蔬菜摄入量低的患者中(OR = 1.72,95%CI = 1.15-2.58,P = 0.01,(校正 P = 0.02)),身体活动量低的患者中(OR = 1.93,95%CI = 1.26-2.94,P = 0.0035,(校正 P = 0.007)),以及非吸烟者中(OR = 1.65,95%CI = 1.11-2.46,P = 0.02)。该 SNP 与体重指数(BMI)增加相关(P = 0.006),血栓动力学参数恶化(形成凝块的最大光密度,D(P = 0.02),自发凝块出现延迟,Tsp(P = 0.02),凝血激活后 30 分钟凝块大小,CS(P = 0.036))。SNP rs17078346 与肥胖个体中 BMI 增加(P = 0.01)和重症 COVID-19 相关(风险等位基因 C,OR = 1.72,95%CI = 1.15-2.58,P = 0.01,(校正 P = 0.02))。SNP rs12610495 与 BMI 增加(P = 0.01)、肥胖患者中的重症 COVID-19 相关(风险等位基因 G,OR = 1.48,95%CI = 1.09-2.01,P = 0.01,(校正 P = 0.02)),以及血栓动力学参数恶化(凝块生长开始时间,Tlag(P = 0.01))相关。对于 rs7949972,在非肥胖患者中观察到对重症 COVID-19 的保护作用(效应等位基因 T,OR = 0.67,95%CI = 0.47-0.95,P = 0.02,(校正 P = 0.04)),改善了血栓动力学参数(CS(P = 0.02),静态空间凝块生长速率,Vst(P = 0.02))。最后,rs12585036 在男性中对重症 COVID-19 表现出保护作用(保护等位基因 A,OR = 0.51,95%CI = 0.32-0.83,P = 0.004)。SNP rs67579710、-、rs17713054、rs7949972、rs9636867 参与了两个或更多最显著的基因-基因相互作用(P≤0.01)。成对组合 rs67579710、-×rs17713054 在确定重症 COVID-19 易感性方面具有优先性(它包含在五个最显著的 SNP-SNP 相互作用模型中的四个中)。
总体而言,本研究代表了对 GWAS 显著位点参与重症 COVID-19 分子机制、基因-基因和基因-环境相互作用的全面分子遗传学和生物信息学分析,并提供了它们与重症监护病房住院患者血栓炎症参数关系的证据。